BELLEVUE GROUP AG – Apellis Pharmaceuticals, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$68.80M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.49% | -198.97K shares | 14.25M | $68.3 | 1.00M |
| Q2 2022 | share | Increase | +9.80% | 107.71K shares | -1.27M | $45.22 | 1.20M |
| Q1 2022 | share | Increase | +68.88% | 448.12K shares | 25.06M | $50.81 | 1.09M |
| Q4 2021 | share | Increase | +1255.40% | 602.59K shares | 29.17M | $47.95 | 650.59K |
| Q3 2021 | share | 0.00% | 0 shares | -1.45M | $32.96 | 48K | |
| Q2 2021 | share | 0.00% | 0 shares | 974K | $63.2 | 48K | |
| Q1 2021 | share | 0.00% | 0 shares | -686K | $42.91 | 48K | |
| Q4 2020 | share | Increase | 0.00% | 48K shares | 2.74M | $57.2 | 48K |
| Q2 2020 | share | Decrease | -100.00% | -29.9K shares | -801K | $32.66 | 0 |
| Q1 2020 | share | Increase | 0.00% | 29.9K shares | 801K | $26.79 | 29.9K |